Tradestie Institutional Equity Comparison Engine

EFIV vs SPXV โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

SPXV Overall Edge

SPXV Captures Institutional Edge (2โ€“0 Pillars ยท 2โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to ProShares S&P 500 Ex-Health Care ETF (SPXV) driven by superior Momentum & Technical, Options & Structure. Fundamentally, EFIV trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus SPXV at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, EFIV sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against SPXV sits in UNCLASSIFIED (92nd %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
EFIV N/M vs SPXV N/M Fwd P/E
Growth & Margin Winner Tie
Op Margin N/A vs N/A ยท YoY N/A vs N/A
Momentum & Technical Winner SPXV
1Y +7.9% vs +8.4% ยท 52W Pos 59% vs 65%
Options & Structure Winner SPXV
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (92nd %ile IV)
EFIV NYSE Arca
Spdr S&P 500 Esg Etf
Institutional Equity
$69.99
-1.9% 1D
Market Cap N/A
1M Return -5.39%
1Y Return +7.94%
Forward P/E N/M
Unified AI Score
50.9 / 100 HOLD
Tech 40.0 Fund 59.0 Flow 50.0 Mom 60.0
SPXV NYSE Arca
ProShares S&P 500 Ex-Health Care ETF
Institutional Equity
$79.74
-2.1% 1D
Market Cap N/A
1M Return -4.15%
1Y Return +8.44%
Forward P/E N/M
Unified AI Score
59.8 / 100 HOLD
Tech 74.0 Fund 58.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: EFIV +7.94% SPXV +8.44% Spread: +0.91 pp (SPXV Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
EFIV TTM Op. Margin: N/A SPXV TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on EFIV vs SPXV. Trailing 12-month operating profitability (EFIV N/A vs SPXV N/A) and valuation multiples (EFIV N/M vs SPXV N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: EFIV (1) vs SPXV (2)
Institutional Metric EFIV SPXV Criterion Row Winner
Market Capitalization Scale N/A N/A Larger Scale Tie
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth N/A N/A Higher Growth Tie
Operating Margin (TTM) Profitability N/A N/A Higher Margin Tie
Net Profit Margin Profitability N/A N/A Higher Margin Tie
Return on Equity (ROE) Capital Efficiency N/A N/A Higher ROE Tie
52-Week Range Position Momentum 59% ($61โ€“$76) 65% ($69โ€“$86) Stronger Trend SPXV
Beta / 30D Volatility Risk Regime 0.99ฮฒ ยท 22% Vol 1.06ฮฒ ยท 23% Vol Lower Realized Risk EFIV
Unified Institutional Score Composite Signal 50.9 / 100 (HOLD) 59.8 / 100 (HOLD) Higher Composite SPXV

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full EFIV vs SPXV Buy Guide
EFIV UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live EFIV Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
SPXV UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 92nd %ile
IV Regime Extreme (>80th %ile)
Live SPXV Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither EFIV nor SPXV registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.